Vimarsana
Biggest News Aggregation in the World

Page 39 - Operations Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Operations Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Operations Data Today - Breaking & Trending Today

PAYLOCITY : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Vimarsana News

PAYLOCITY : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)

Message : Required fields The statements included herein that are not based solely on historical facts are "forward looking statements." Such forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties. Our actual results could differ materially from those anticipated by us in these forward-looking statements as a result of various factors, including those discussed below and under "Item 1A. Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2020 filed with the SEC on August 7, 2020. Overview We are...

Provention Bio Reports First Quarter 2021 Financial Results and Provides Business Update - Vimarsana News

Provention Bio Reports First Quarter 2021 Financial Results and Provides Business Update

Provention Bio Reports First Quarter 2021 Financial Results and Provides Business Update News provided by Share this article Share this article RED BANK, N.J., May 6, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today reported financial results and provided a business update for the first quarter ended March 31, 2021. "The first quarter of 2021 marked another quarter of strong execution across Provention Bio as we continue to advance our portfolio of autoimmunology therapeutic candidate...

ChemoCentryx Reports First Quarter 2021 Financial Results - Vimarsana News

ChemoCentryx Reports First Quarter 2021 Financial Results

-- Applications for regulatory approval of avacopan in ANCA-associated vasculitis under review in the United States, Europe and Japan; PDUFA goal date of...

Strong Start to the Year With a Solid Set of Results: Turkcell Iletisim Hizmetleri: First Quarter 2021 Results - Vimarsana News

Strong Start to the Year With a Solid Set of Results: Turkcell Iletisim Hizmetleri: First Quarter 2021 Results

Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell Iletisim Hizmetleri A.S. (the "Company", or "Turkcell") and its subsidiaries and associates (together referred to as the "Group"), unless otherwise stated. We have four reporting segments: "Turkcell Turkey" which comprises our telecom, digital services and digital business services related businesses in Turkey (as used in our previous releases in periods prior to Q115, this term covered only the mobile businesses). All non-financial data presented in th...

MYR Group Inc. Announces First-Quarter 2021 Results - Vimarsana News

MYR Group Inc. Announces First-Quarter 2021 Results

MYR Group Inc. Announces First-Quarter 2021 Results HENDERSON, Colo., April 28, 2021 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and western Canada, today announced its first-quarter 2021 financial results. Highlights for First Quarter 2021 Strong quarterly revenues of $592.5 million Record high quarterly net income of $19.9 million, or $1.17 per diluted share Record high quarterly EBITDA of $39.3 million Stron...